Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-18 Purchase |
2024-09-19 8:21 pm |
Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner |
125,000 | $0.75 | $93,750 | 11,440,865 (Indirect Direct) |
View |
| 2024-05-20 Purchase |
2024-05-21 3:14 pm |
Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner |
100,000 | $0.75 | $75,000 | 11,315,865 (Indirect Direct) |
View |
| 2023-12-19 Purchase |
2023-12-20 2:05 pm |
Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner |
150,000 | $0.5 | $75,000 | 11,215,865 (Indirect Direct) |
View |
| 2023-08-01 Purchase |
2023-08-04 1:41 pm |
Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner |
62,500 | $2 | $125,000 | 11,065,865 (Indirect Direct) |
View |
| 2022-11-09 Sale |
2022-11-14 6:43 pm |
Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO |
162,500 | $1.5 | $243,750 | 1,975,358 (Direct) |
View |
| 2022-04-29 Purchase |
2022-05-02 12:21 pm |
Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner |
804,868 | $1 | $804,868 | 11,003,365 (Indirect Direct) |
View |
| 2020-10-05 Purchase |
2022-04-26 9:24 pm |
Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner |
175,000 | $0.4 | $70,000 | 10,500,702 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-11-15 Exercise |
2024-11-19 5:51 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner |
33,334 | $0.5 | 5,396,054 (Direct) |
View |
| 2024-11-15 Exercise |
2024-11-19 5:51 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner |
184,375 | $0.4 | 5,396,054 (Direct) |
View |
| 2018-08-09 Exercise |
2024-11-19 5:51 pm |
2018-08-09 2025-08-09 |
Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner |
217,709 | $0 | 5,396,054 (Direct) |
View |
| 2024-07-17 Option Award |
2024-07-22 6:58 pm |
2025-07-17 2034-07-17 |
Nuo Therapeutics Inc. | AURX | WINZER C ERIC Director |
40,000 | $0.33 | 40,000 (Direct) |
View |
| 2024-07-17 Option Award |
2024-07-22 6:55 pm |
2025-07-17 2034-07-17 |
Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner |
40,000 | $0.33 | 40,000 (Direct) |
View |
| 2024-07-17 Option Award |
2024-07-22 6:50 pm |
2025-07-17 2034-07-17 |
Nuo Therapeutics Inc. | AURX | Mintz Paul Director |
25,000 | $0.33 | 25,000 (Direct) |
View |
| 2024-05-20 Option Award |
2024-05-21 3:13 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | CLAUSEN PETER CSO/COO |
15,000 | $0.75 | 589,675 (Direct) |
View |
| 2024-05-20 Option Award |
2024-05-21 3:11 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner |
135,000 | $0.75 | 5,178,345 (Direct) |
View |
| 2023-12-19 Option Award |
2023-12-20 2:04 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | CLAUSEN PETER CSO/COO |
20,000 | $0.5 | 574,948 (Direct) |
View |
| 2023-12-19 Option Award |
2023-12-20 2:03 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner |
600,000 | $0.5 | 5,043,345 (Direct) |
View |
| 2023-08-01 Option Award |
2023-08-03 4:18 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | CLAUSEN PETER CSO/COO |
25,000 | $2 | 554,948 (Direct) |
View |
| 2023-08-01 Option Award |
2023-08-03 4:17 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner |
100,000 | $2 | 4,443,345 (Direct) |
View |
Ownership(A) |
2022-10-18 1:20 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | CLAUSEN PETER CSO/COO |
0 | $0 | 769,778 (Direct) |
View |
| 2022-06-06 Option Award |
2022-06-15 6:18 pm |
2022-03-04 2032-03-04 |
Nuo Therapeutics Inc. | AURX | CLAUSEN PETER CSO/COO |
275,000 | $0 | 275,000 (Direct) |
View |
| 2022-04-29 Option Award |
2022-05-02 12:23 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO |
10,532 | $1 | 2,137,858 (Direct) |
View |
| 2022-04-29 Option Award |
2022-05-02 12:23 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | CLAUSEN PETER CSO/COO |
25,000 | $1 | 529,948 (Direct) |
View |
| 2022-04-29 Option Award |
2022-05-02 12:22 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner |
100,000 | $1 | 4,343,345 (Direct) |
View |
Ownership |
2022-04-26 9:36 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | CLAUSEN PETER CSO/COO |
0 | $0 | 504,948 (Direct) |
View |
| 2022-03-04 Option Award |
2022-04-26 9:35 pm |
2022-03-04 2032-03-04 |
Nuo Therapeutics Inc. | AURX | Mintz Paul Director |
101,666 | $0 | 101,666 (Direct) |
View |
| 2022-03-04 Option Award |
2022-04-26 9:34 pm |
2022-03-04 2032-03-04 |
Nuo Therapeutics Inc. | AURX | WINZER C ERIC Director |
111,666 | $0 | 111,666 (Direct) |
View |
| 2022-03-04 Option Award |
2022-04-26 9:32 pm |
2022-03-04 2032-03-04 |
Nuo Therapeutics Inc. | AURX | CLAUSEN PETER CSO/COO |
43,328 | $0 | 43,328 (Direct) |
View |
| 2022-03-04 Option Award |
2022-04-26 9:31 pm |
2022-03-04 2032-03-04 |
Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner |
133,334 | $0 | 133,334 (Direct) |
View |
| 2022-03-04 Option Award |
2022-04-26 9:29 pm |
2022-03-04 2032-03-04 |
Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO |
191,672 | $0 | 191,672 (Direct) |
View |
| 2021-12-30 Ownership |
2022-04-26 9:28 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner |
1,431,615 | $0.2 | 11,630,112 (Direct) |
View |
| 2021-12-30 Ownership |
2022-04-26 9:28 pm |
2021-12-01 2022-01-31 |
Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner |
1,431,615 | $0 | 11,630,112 (Direct) |
View |
| 2021-12-01 Ownership |
2022-04-26 9:28 pm |
2021-12-01 2022-01-31 |
Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner |
2,863,230 | $0 | 11,630,112 (Direct) |
View |
Ownership |
2022-04-26 9:28 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner |
0 | $0 | 11,630,112 (Indirect) |
View |
| 2021-12-01 Ownership |
2022-04-26 9:26 pm |
2021-12-01 2022-01-31 |
Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner |
1,222,635 | $0 | 6,365,980 (Direct) |
View |
| 2021-12-30 Ownership |
2022-04-26 9:26 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner |
900,000 | $0.2 | 6,365,980 (Direct) |
View |
| 2021-12-06 Ownership |
2022-04-26 9:26 pm |
2021-12-01 2022-01-31 |
Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner |
322,635 | $0 | 6,365,980 (Direct) |
View |
| 2021-12-30 Ownership |
2022-04-26 9:26 pm |
2021-12-01 2022-01-31 |
Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner |
900,000 | $0 | 6,365,980 (Direct) |
View |
| 2021-12-01 Ownership |
2022-04-26 9:25 pm |
2021-12-01 2022-01-31 |
Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO |
1,297,635 | $0 | 4,562,596 (Direct) |
View |
| 2021-12-30 Ownership |
2022-04-26 9:25 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO |
1,137,635 | $0.2 | 4,562,596 (Direct) |
View |
| 2021-12-06 Ownership |
2022-04-26 9:25 pm |
2021-12-01 2022-01-31 |
Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO |
160,000 | $0 | 4,562,596 (Direct) |
View |
| 2021-12-30 Ownership |
2022-04-26 9:25 pm |
2021-12-01 2022-01-31 |
Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO |
1,137,635 | $0 | 4,562,596 (Direct) |
View |
| 2020-10-05 Ownership |
2022-04-26 9:24 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner |
302,205 | $0.4 | 10,500,702 (Direct) |
View |
| 2020-10-05 Ownership |
2022-04-26 9:24 pm |
2020-10-05 2025-10-05 |
Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner |
1,596,615 | $0 | 10,500,702 (Direct) |
View |
Ownership |
2022-04-26 9:24 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | SHEEDY CHARLES E 10% Owner |
0 | $0 | 10,500,702 (Indirect) |
View |
| 2020-10-05 Ownership |
2022-04-26 9:23 pm |
2020-10-05 2025-10-05 |
Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner |
1,222,635 | $0 | 4,565,980 (Direct) |
View |
| 2020-10-05 Ownership |
2022-04-26 9:23 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | Pittman Scott M. Director 10% Owner |
407,545 | $0.4 | 4,565,980 (Direct) |
View |
| 2020-10-05 Ownership |
2022-04-26 9:22 pm |
2020-10-05 2025-10-05 |
Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO |
1,297,635 | $0 | 2,287,326 (Direct) |
View |
| 2020-10-05 Ownership |
2022-04-26 9:22 pm |
N/A N/A |
Nuo Therapeutics Inc. | AURX | JORDEN DAVID EMERSON CEO/CFO |
432,545 | $0.4 | 2,287,326 (Direct) |
View |